ECO 2026 12 - 15 May 2026

CagriSema Reduces Predicted Atherosclerotic Cardiovascular Disease Risk in Adults With Overweight or Obesity: The REDEFINE 1 Trial

Authors :

Subodh Verma¹; Morten Böttcher²; Paul Brown³; Dror Dicker⁴; Domenica Rubino⁵; Paolo Sbraccia⁶; Arya M. Sharma⁷; Lærke Smedegaard³; Rasmus Sørrig³; W. Timothy Garvey⁸

Affiliations

View Details Hide Details

{{ getPageNum(PDFPage) }}

Keywords

Obesity

Congress oral presentation

Amylin

CagriSema

PHASE 3 (RCT)